New Orleans 2026

INNOVATORS POP-UP | MOMENTS OF WONDER
October 8, 2026

Mardi Gras World
1380 Port of New Orleans Place
New Orleans, LA 70130

Register Now

Every Great Innovation Begins with a Moment of Wonder.

A question.

An unexpected conversation.

A technology you’ve never seen before.

A connection that changes everything.

Innovators Pop-Up is built around these moments – the ones that spark curiosity, challenge assumptions, and inspire what’s next in ophthalmology.

Join physicians, founders, investors, strategic partners, and industry leaders for an immersive evening where innovation isn’t simply displayed—it comes to life.

This is not your average reception.

It’s where wonder leads to what’s next.

Showcase Innovators

SPONSORS

2EyesVision

2eyesvision.com

2EyesVision is a medical technology company transforming how patients experience and understand their vision before eye surgery.

Its flagship product, the SimVis Gekko, enables patients to experience different intraocular lens (IOL) options to correct their vision through a real-world experience before a procedure, helping eye care professionals support more informed clinical decisions, align expectations, and improve the overall patient experience.

20/20 Onsite

2020onsite.com

20/20 Onsite is a specialty vendor for sponsors and CROs conducting clinical trials with ocular endpoints, providing end-to-end ophthalmic trial consultation, clinical field execution, and ongoing support. Through a single-call accountability model, 20/20 Onsite helps sponsors de-risk ocular endpoint complexity and increase the likelihood of on-time, on-budget, protocol-adherent trial success.

Its proprietary point-of-need service delivery model reaches participants where they live, work, or congregate, reducing patient burden, improving retention, and supporting diverse enrollment strategies. Backed by proven expertise, nationwide experience at scale, and validated regulatory rigor, 20/20 Onsite has supported more than 45 clinical trials, served over 100,000 patients, and consistently delivered Net Promoter Scores above 95.

To learn more about how 20/20 Onsite delivers single-call ophthalmic execution for trials with ocular endpoints, visit www.2020onsite.com.

Advancing Eyecare

advancingeyecare.com

Advancing Eyecare™ is an alliance of leading companies in the eyecare instrumentation marketplace, established to offer the best products and service solutions in the ophthalmic equipment industry.

Currently comprised of Marco Lombart, Eyefficient, Santinelli International, Enhanced Medical Services (EMS), Veatch Ophthalmic Instruments, INNOVA Medical, S4Optik, and Birmingham Optical, together these companies deliver the broadest portfolio of products, the most knowledgeable people, and the most reliable service in the industry to eyecare practices across North America and the United Kingdom. Portfolio expertise spans pre-test technologies, exam lane equipment, optical finishing, and advanced diagnostic and surgical solutions.

Advancing Eyecare is headquartered in Jacksonville, Florida. For more information, visit www.advancingeyecare.com.

Eye to Eye

eyetoeyetelehealth.com

Eye to Eye is digitally transforming glaucoma care via a data-connected technology ecosystem rooted in home IOP monitoring.

Healio AI

healio.com/ai

Healio AI is a generative AI tool designed specifically for physicians and other healthcare professionals.

It provides content in response to questions using natural language processing. Healio AI uses a state-of-the-art large language model paired with an embedding model specifically designed for medical and clinical data.

Because Healio is a medical publishing and education company, it creates unique, timely content that forms the foundation of Healio AI—ensuring the tool reflects current clinical knowledge and real-world needs.

The platform is free to use and HIPAA compliant, with privacy and security built into its design.

NeuroTrigger

nt-med.com

Facial paralysis affects millions and often eliminates blinking, causing dry eye, pain, and visual decline.

NeuroTrigger’s FDA‑approved NTBasic device is the first home‑use wearable device that restores eyelid closure. With a stimulator, daily electrode, and App‑controlled pacing, NTBasic delivers true functional restoration, improving comfort and vision while opening a large, underserved global market.

The company is preparing a U.S. soft launch in select centers in the coming months.

RadiusXR

radiusxr.com

RadiusXR is a technology company at heart, with a passion for solving complex healthcare issues. Our current focus is transforming the way we look at vision testing and eye care, with an advanced digital platform that enables unrivaled patient access, streamlines operations, and creates more confidence at the point of decision-making.

Our clinically validated, portable platform integrates seamlessly into existing systems, with customized software and cloud technology to securely manage data. A lightweight, purpose-built headset is designed to enhance patient comfort, featuring advanced analysis tools that support clinicians in assessing visual function.

We continue searching for ways to disrupt the healthcare industry’s status quo with our advanced wearable technologies. Our goal is to help ophthalmologists and optometrists treat more patients with unrivaled accuracy and introduce vision testing into primary care practices or other unexpected settings to increase patient access and reduce long-term health issues like eye disease.

Valitor Inc

www.valitorbio.com

Valitor is conquering limitations of established drug targets by leveraging its multivalent biopolymer technology to maximize benefits for patients. The company is initially focused on developing long-acting molecules aimed at capturing several large markets in ophthalmology. Valitor’s lead product is a long-acting inhibitor of VEGF designed to reliably extend the duration of a single dose in humans to six months or more, which would offer a substantial benefit for the majority of patients that require dosing approximately every 8-12 weeks with the current market leaders. Valitor’s proprietary platform technology has been shown in preclinical models to safely enable intravitreal treatment with unprecedented target tissue durability and potency. For more information on the company, please visit its website at https://www.valitorbio.com/.

Amaros

amaros.ai

Amaros’ EvidenceEngine™ is an AI-powered platform designed to unify and transform fragmented ophthalmic data into actionable intelligence, revolutionizing clinical development, research, and therapeutic decision-making across the eye care continuum. Built in Silicon Valley and backed by serial ophthalmic entrepreneurs, AI scientists, clinicians, and CRO experts, the platform targets a critical bottleneck in ophthalmology: disconnected datasets that hinder efficient trials, slow adoption of therapies, and limit patient access.

Bausch + Lomb

bausch.com

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life.

Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries.

Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.

True North

https://truenorthcro.com/

True North Contract Research is a dynamic and rapidly growing Contract Research Organization (CRO) specializing in Ophthalmology research. We strive to deliver an experience that is second to none to our sponsor partners and site partners. Our longstanding commitment to advancing the field of ophthalmology through clinical research has provided us with the experience to execute trials efficiently with a focus on accuracy and compliance. We merge FDA and clinical site perspectives to identify effective solutions that are agreeable to both parties and then mitigate roadblocks to achieve trial endpoints. One of our greatest strengths is uniting with sponsoring companies as a seamless team that makes well thought through decisions in a timely manner. True North was founded on the principles of:

  • Always do the right thing.
  • Be a good partner, in business and in life.
  • Provide future generations with better care.

Visionary Ventures

visionaryvc.com

Visionary Ventures is a venture capital fund that invests in life sciences and the future of ophthalmology and medical aesthetics. We are an opportunistic venture fund that invests in early and late stages of a company’s growth, from early-stage Series A rounds in clinical trials to late-stage rounds in commercialization. Our target investment range is $5M to $15M.